Table 2.

Overall susceptibility of 136 Paenibacillus spp. isolates from human and environmental sources in Spain

Antibiotic	MIC (mg/L)			Breakpoint (mg/L)		Percentage of isolates
	Range	50a	90a	Susceptibility	Resistance	Susceptible	Intermediate	Resistant
Ampicillin	0.06 to ≥256	16	≥256	≤0.25	≥0.5	4.4	—	95.6
Cefotaxime	0.03 to ≥256	2	≥256	≤8	≥64	70.6	2.2	27.2
Erythromycin	0.06 to ≥256	1	16	≤0,5	≥8	36.0	50.1	13,9
Minocycline	≤0.016 to 48	0.03	8	≤4	≥16	87.5	4.4	8.1
Gentamicin	≤0.0016 to ≥256	0.5	3	≤4	≥16	95.6	1.5	2.9
Cotrimoxazole	0.003 to ≥32	0.5	≥32	≤2	≥4	56	—	44
Rifampicin	0.003 to ≥32	0.25	8	≤1	≥4	76.4	10.3	13.2
Vancomycin	0.03 to ≥256	3	12	≤4	>4	78.7	—	21.3

MIC, minimum inhibitory concentration.

^aMICs at which 50 and 90% of the isolates were inhibited, respectively.